Please assess the completion status of the following clinical trial:

Trial Title: Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women with primary breast cancer who are candidates for radical surgery.~* Breast tumours clinically ≥ 15 mm, Nx, M0.~* Breast tumours identified on mammography and verified on fine needle aspiration.~* Age \> 18 years.~* Performance status of ECOG ≤ 1.~* Laboratory requirements at the day of diagnosis (t1-):Prior to inclusion a normal renal (serum creatinine) and hepatic (transaminases) function (within normal limits) estimated in blood samples is required.~* Prior to patient registration, written informed consent must be given according to ICH/GCP, and national/local regulations.~* Negative pregnancy test for pre menopausal women before inclusion in the trial~Exclusion Criteria:~* Ongoing cholesterol lowering therapy (statins, fibrates, ezetimibe).~* Prior breast cancer treatment.~* Current HRT.~* Known liver disease.~* History of hemorrhagic stroke.~* Psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; these conditions will be discussed with the patient before registration in the trial.~* History of allergic reactions attributed to compounds of similar chemical or biological composition to atorvastatin.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Atorvastatin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).